Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Healthequity (HQY) EBITDA (2016 - 2026)

Healthequity (HQY) has 13 years of EBITDA data on record, last reported at $78.7 million in Q4 2025.

  • For Q4 2025, EBITDA rose 1279.89% year-over-year to $78.7 million; the TTM value through Oct 2025 reached $248.6 million, up 157.07%, while the annual FY2025 figure was $96.7 million, 73.58% up from the prior year.
  • EBITDA reached $78.7 million in Q4 2025 per HQY's latest filing, down from $89.6 million in the prior quarter.
  • Across five years, EBITDA topped out at $89.6 million in Q3 2025 and bottomed at -$32.8 million in Q1 2022.
  • Average EBITDA over 5 years is $15.5 million, with a median of $5.5 million recorded in 2021.
  • Peak YoY movement for EBITDA: plummeted 2479.73% in 2021, then soared 12714.35% in 2024.
  • A 5-year view of EBITDA shows it stood at -$5.0 million in 2021, then surged by 67.43% to -$1.6 million in 2022, then surged by 994.15% to $14.7 million in 2023, then plummeted by 61.13% to $5.7 million in 2024, then surged by 1279.89% to $78.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA were $78.7 million in Q4 2025, $89.6 million in Q3 2025, and $53.9 million in Q2 2025.